IBEX COO sells 17,500 shares at about $37

IBEX’s Chief Operating Officer sold 17,500 common shares under a pre-arranged Rule 10b5-1 trading plan and now directly holds 140,006 shares.

Rhea-AI Filing Summary

IBEX Ltd (IBEX) reported that its Chief Operating Officer, David Martin Afdahl, sold common shares in an open-market transaction. On September 8, 2026, he sold 17,500 common shares at a weighted average price of $37.0862 per share, pursuant to a Rule 10b5-1 trading plan dated June 8, 2026. Following this sale, he directly owns 140,006 common shares of IBEX Ltd.

Insider Trade Summary 10b5-1

Net Seller: 17,500 shares

Net Sell 1 txn

Insider Afdahl David Martin

Role Chief Operating Officer

Sold 17,500 shs ($649K)

Type	Security	Shares	Price	Value
Sale	Common Shares F1, F2	17,500	$37.0862	$649K

Holdings After Transaction: Common Shares — 140,006 shares (Direct)

Footnotes (2)

1. F1. This sale was made pursuant to the Reporting Person's 10b5-1 Plan, dated June 8, 2026.
2. F2. This transaction was executed in multiple trades at prices ranging from $36.84 to $38.33; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Key Figures

Shares sold: 17,500 shares Weighted average sale price: $37.0862 per share Post-transaction holdings: 140,006 shares +2 more

5 metrics

Shares sold 17,500 shares Common shares sold by the Chief Operating Officer on September 8, 2026

Weighted average sale price $37.0862 per share Weighted average price for the 17,500 common shares sold on September 8, 2026

Post-transaction holdings 140,006 shares Common shares directly owned by the Chief Operating Officer after the sale

Price range of executed trades $36.84 to $38.33 per share Range of individual trade prices for the September 8, 2026 sale

Rule 10b5-1 plan date June 8, 2026 Date of the trading plan under which the reported sale occurred

Key Terms

Rule 10b5-1 Plan, weighted average sales price, multiple trades

3 terms

Rule 10b5-1 Plan regulatory

"This sale was made pursuant to the Reporting Person's 10b5-1 Plan, dated June 8, 2026."

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

weighted average sales price financial

"the price reported above reflects the weighted average sales price."

multiple trades financial

"This transaction was executed in multiple trades at prices ranging from $36.84 to $38.33;"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did IBEX (IBEX) disclose in this Form 4?

IBEX disclosed that Chief Operating Officer David Martin Afdahl sold 17,500 common shares on September 8, 2026 in an open-market transaction, with the sale reported at a weighted average price of $37.0862 per share.

How many IBEX (IBEX) shares does the COO hold after this transaction?

After the reported sale, Chief Operating Officer David Martin Afdahl directly holds 140,006 common shares of IBEX Ltd, as stated in the Form 4 filing.

Was the IBEX (IBEX) insider sale made under a Rule 10b5-1 plan?

Yes. The filing states that the sale was made pursuant to the reporting person’s Rule 10b5-1 Plan dated June 8, 2026, indicating it was pre-arranged under that trading plan.

What price did the IBEX (IBEX) COO receive for the shares sold?

The transaction was executed in multiple trades at prices ranging from $36.84 to $38.33 per share. The Form 4 reports a weighted average sales price of $37.0862 per share for the 17,500 shares sold.

What role does the reporting person hold at IBEX (IBEX)?

The reporting person, David Martin Afdahl, is identified in the Form 4 as the Chief Operating Officer of IBEX Ltd.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/10/2026 - 08:40 PM EDT Accepted by SEC EDGAR 09/10/2026 - 08:39 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Afdahl David Martin

(Last) (First) (Middle)

C/O IBEX LIMITED

1717 PENNSYLVANIA AVENUE NW, SUITE 825

(Street)

WASHINGTON DISTRICT OF COLUMBIA 20006

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IBEX Ltd [ IBEX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	09/08/2026		S(1)		17,500	D	$37.0862(2)	140,006	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This sale was made pursuant to the Reporting Person's 10b5-1 Plan, dated June 8, 2026.

2. This transaction was executed in multiple trades at prices ranging from $36.84 to $38.33; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Remarks:

	Lisa Lenstrohm, Attorney-in-Fact	09/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)